Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. [electronic resource]
Producer: 20081211Description: 2080-90 p. digitalISSN:- 1476-5551
- Animals
- Annexin A5 -- metabolism
- Apoptosis -- drug effects
- Blotting, Western
- Caspases -- metabolism
- Cells, Cultured
- Cysteine Proteinase Inhibitors -- pharmacology
- Doxorubicin -- pharmacology
- Drug Resistance
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Genes, Dominant
- Hematopoietic Stem Cells -- drug effects
- Imidazoles -- pharmacology
- Leupeptins -- pharmacology
- Mice
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Proto-Oncogene Proteins c-mdm2 -- antagonists & inhibitors
- Reverse Transcriptase Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- antagonists & inhibitors
- raf Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.